The pharmacokinetics of pulmonary nebulized insulin and its effect on glucose tolerance in streptozotocin-induced diabetic rabbits

International Journal of Pharmaceutics

Volumn 128, Issue 1-2, 1996, Pages 215-222

  Sakr, Farouk M ^a,b  

^a Ministry of Health United Arab Emirates   (United Arab Emirates)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

bioavailability; diabetes; glucose; insulin; nebulizer; pharmacokinetics; pu lmonary administration; streptozotocin; subcutaneous administration

Indexed keywords

INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE TOLERANCE; INHALATIONAL DRUG ADMINISTRATION; NEBULIZER; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RABBIT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029925622     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04310-1     Document Type: Article

References (13)

1. Colthorpe, P., Farr, S.J., Taylor, G., Smith, I.J. and Wyatt, D., The Pharmacokinetics of pulmonary delivered insulin: a comparison of intratracheal and aerosol administration to rabbits. Pharm. Res., 9(6) (1992) 764-768.
2. Crommelin, D., Peptides and proteins: A challenge for drug delivery. Acta Pharm. Technol., 33 (1987) 1-2.
3. Gillies, H.C., Rogers, H.J., Spector, R.G. and Trounce, J.R., Diabetes mellitus. In Textbook of Clinical Pharmacology, 2nd Edn, Hodder and Stoughton, London 1986, pp. 648-658.
4. Jones, A.L., Kellaway, I.W. and Taylor, G., Pulmonary absorption of aerosolised insulin in rabbits. J. Pharm. Pharmacol., (1988) 92.
5. Larner, J., Insulin and oral hyperglycaemic drugs; glucagon. In Gilmaman, A. G., Goodman, K. S., Rail, T. W. and Murad, F. (Eds), The Pharmacological Basis of Therapeutics, 7th. Edn., Macmillan, New York, 1984, pp. 1490-1516.
6. Nagai, T., Adhesive topical drug delivery system, In Anderson, J. M. and Kim, S. W. (Eds), Advances in drug delivery systems. Controlled Release Series, Elsevier, Amsterdam, Vol 1, 1986, pp. 121-134.
7. Nishihata, T., Okamura, Y., Kamada, A., Higuchi, T., Yagi, T., Kawamori, R. and Schichiri, M., Enhanced bioavailability of insulin after rectal administration with enamine as adjuvant in depancreatized dogs. J. Pharm. Pharmacol., 37 (1985) 22-26.
8. Nishihata, T., Sudoh, M., Inagaki, H., Kawada, A., Yagi, T., Kawamori, R. and Schichiri, M., An effective formulation for an insulin suppository; Examination in normal dogs. Int. J. Pharm., 38 (1987) 83-90.
9. Reynolds, J.E.F. (Ed.) Insulin. In: Martindale, The Extra Pharmacopoeia. The Pharmaceutical Press, London, 1993, pp. 281-289.
10. Richardson, J.L., Illum, L., Thomas, N.W., Vaginal absorption of insulin in the rats: Effect of penetration enhancers on insulin up-take and mucosal histology. Pharm. Research, 9(7) (1992) 878-883.
11. Rottiers, R., Mattheeuws, J.J., Koneko and Vermeulin, A., Glucose uptake and insulin secretory responses to intravenous glucose loads in the dog. Amer. J. Vet Res., 42 (1981) 155-158.
12. Sakr, F.M., A new approach for insulin delivery via the pulmonary route: Design and pharmacokinetics in non-diabetic rabbits. Int. J. Pharm., 86 (1992) 1-7.
13. Yamasaki, Y., Schichiri, M., Kikuchi. R., Yagi, T., Arai, S., Hakui, N., Oji, N. and Abe, H., The effectiveness of rectal administration of insulin suppository on normal and diabetic subjects. Diabetes Care, 4 (1981) 454-458.